[Current management of Fabry disease].
Pierre Cochat(Société Nationale des Chemins de Fer Français (France)), Thierry Levade(Inserm), A. Liutkus(Hôpital Femme Mère Enfant), Laurence Dubourg(Lyon 1 Université)
PubMed
January 1, 2006
Cited by 1
Related Papers
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
|New England Journal of Medicine|2021|509
An estimated glomerular filtration rate equation for the full age spectrum
|Nephrology Dialysis Transplantation|2016|489
Development and Validation of a Modified Full Age Spectrum Creatinine-Based Equation to Estimate Glomerular Filtration Rate
|Annals of Internal Medicine|2020|400
Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy
|Kidney International|2011|361
CKD: A Call for an Age-Adapted Definition
|Journal of the American Society of Nephrology|2019|358